Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports results from a study evaluating the effect of Filgotinib on semen parameters in adult males with active rheumatoid arthritis, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Filgotinib (filgotinib)

Snippet

Sponsor: Galapagos NV | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01